Zhigang J. Bai

95 Yong'an Road
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Clinical practice of preoperative interventional embolization combined with robotic surgery in the treatment of adrenal pheochromocytoma

Clinical practice of preoperative interventional embolization combined with robotic surgery in the treatment of adrenal pheochromocytoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: July 21, 2026

Combination of PD-1 blockade and neoadjuvant chemoradiotherapy benefits pMMR/MSS patients with locally advance rectal cancer: A phase 2 clinical trial.

Combination of PD-1 blockade and neoadjuvant chemoradiotherapy benefits pMMR/MSS patients with locally advance rectal cancer: A phase 2 clinical trial.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: January 16, 2026

Development of a predictive tool for long-term prognosis in clear cell adenocarcinoma of the cervix: a large population-based real-world study.

Development of a predictive tool for long-term prognosis in clear cell adenocarcinoma of the cervix: a large population-based real-world study.

Journal: Frontiers in medicine

Published: April 06, 2025

Efficacy and safety of fruquintinib plus capecitabine as first-line treatment in patients with metastatic colorectal cancer ineligible for intravenous chemotherapy: a two-stage, single-armed, phase II study.

Efficacy and safety of fruquintinib plus capecitabine as first-line treatment in patients with metastatic colorectal cancer ineligible for intravenous chemotherapy: a two-stage, single-armed, phase II study.

Journal: Investigational new drugs

Published: December 24, 2024

Targeting neuronal cuproptosis and neuroinflammation with biomimetic nanoparticle for the therapy of radiotherapy-induced brain injury.

Targeting neuronal cuproptosis and neuroinflammation with biomimetic nanoparticle for the therapy of radiotherapy-induced brain injury.

Journal: Biomaterials

Published: December 17, 2024

Author Correction: Integrated single-cell and bulk RNA-seq analysis identifies a prognostic T-cell signature in colorectal cancer.

Author Correction: Integrated single-cell and bulk RNA-seq analysis identifies a prognostic T-cell signature in colorectal cancer.

Journal: Scientific reports

Published: October 03, 2024

Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study.

Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study.

Journal: The oncologist

Published: March 30, 2024

Integrated single-cell and bulk RNA-seq analysis identifies a prognostic T-cell signature in colorectal cancer.

Integrated single-cell and bulk RNA-seq analysis identifies a prognostic T-cell signature in colorectal cancer.

Journal: Scientific reports

Published: March 24, 2024

Prognosis for local radical treatment in patients with esophageal squamous cell carcinoma with low-risk oligometastatic recurrence after curative resection: a retrospective cohort study.

Prognosis for local radical treatment in patients with esophageal squamous cell carcinoma with low-risk oligometastatic recurrence after curative resection: a retrospective cohort study.

Journal: Journal of gastrointestinal oncology

Published: March 22, 2024

Unraveling the role of tumor sidedness in prognosis of stage II colon cancer.

Unraveling the role of tumor sidedness in prognosis of stage II colon cancer.

Journal: Gastroenterology report

Published: December 01, 2023

Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial).

Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial).

Journal: BMJ open

Published: September 12, 2023

Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study.

Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study.

Journal: Signal transduction and targeted therapy

Published: September 05, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026